Jamey Wachta is a highly-regarded business lawyer with many years of experience handling general healthcare and corporate law, especially sophisticated medical and technology transfer transactions. He represents leading healthcare institutions and technology companies (both bio and high tech), individual physicians and research scientists, and serves as Chairperson of Rackemann’s Medical & Technology Transfer Group.
In addition to medical and technology transfer matters, corporate clients seek Jamey’s expertise with discrete issues involving HIPAA, FDA marketing, contracts, commercial lending, and securities law. He represents major companies and other entities dealing with organization, financing, business and intellectual property issues ­ ranging from acquisitions through exit strategies ­ as well as other complex business law issues.
Jamey joined Rackemann in 1992. Before that, he was with the former firm of Palmer & Dodge in that firm’s Business Law Department. After graduating from law school, he served as law clerk to the Honorable Kenneth F. Ripple, Circuit Judge of the U.S. Court of Appeals for the Seventh Circuit.
Massachusetts hospital network (with Harvard teaching hospitals), as special outside counsel, in a variety of matters and transactions, including policy review and implementation, commercializing technology, licensing arrangements, clinical and sponsored-research issues and the review of consulting agreements for professional staff and employees.
Harvard teaching hospital in the review and negotiation of numerous clinical trial agreements involving a variety of public and private pharmaceutical and medical device companies, as well as foundations and non-profit institutions.
Boston hospital in its joint venture with another major Boston hospital and an HMO to capitalize and operate an ambulatory surgery center.
Physicians and research scientists in all aspects of employment and consulting arrangements, including equity incentives and compensation, with public and private companies.
Buyers and sellers, as well as CEOs and other management individually, in a wide variety of purchase and sale transactions (including mergers, acquisitions and related restructurings) of private companies and divisions of private and public companies.
Manufacturing companies in financing facilities to obtain working capital.
International biotechnology clients, as outside general counsel, for their legal representation in various transactions. These include financings, mergers, licensing and sublicensing issues and general business and contract issues.
Specialized medical device company, as outside general counsel, in a merger with an international public company, resolving many obstacles and resulting in a significant gain to the stockholders of the client. Jamey continues to represent the company after a management buy-back of the company from the acquirer.
Public companies, including his current representation of private business clients in revolving credit and term loan facilities.
Initial public offering of over $14 million of common stock; second public offering of $39.2 million of common stock; and third public offering of $142.8 million of common stock, which then represented the largest single offering of biotechnology stock.
Merger and acquisition activities, including the public registration of over $50 million of common stock and $5 million of warrants.
Private placement of $36.75 million of limited partnership interests in an R&D transaction and the licensing of the underlying technology.
$46 million stock and warrants off-balance sheet research and development subsidiary (SWORDS) transaction and registration of callable common stock and warrants.
Publishing companies in a variety of transactions, ranging from financing facilities to all aspects of various acquisitions.
In the firm’s representation of a state commissioner of insurance (as receiver), Jamey advised and represented the client on corporate issues involved in the sale of companies. He helped with negotiations with an international syndicate of creditors, managing relationships with investment bankers, dealings with the federal bankruptcy court and trustee and advising on other general corporate, bankruptcy and securities matters. Jamey also participated in the reorganization of several insurance company affiliates, including the sale of a major subsidiary and other general corporate and securities matters.
In addition, Jamey spearheaded the sale of certain of the insurance company’s affiliates and assets as part of the firm’s representation of a foreign superintendent of insurance (as liquidator) in the liquidation of a multinational insurance company. He also advised the client on other, related general corporate, liquidation and securities matters.
Senior management, in their general employment relationship with companies, including employment and non-competition agreements, stock options, and personal guarantees.
Start-up companies and single-member entities on all issues from formation to general contract law matters.
Business Transactions Powerlink, Contributing Author, West Group in CD-ROM format.
Spending time with my family, climbing the step mill, and reading.